These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11221022)
1. Current status of irinotecan in lung cancer. Fukuoka M Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):6-7. PubMed ID: 11221022 [TBL] [Abstract][Full Text] [Related]
6. Irinotecan in combination with radiation therapy for small-cell and non-small-cell lung cancer. Wu HG; Choy H Oncology (Williston Park); 2002 Sep; 16(9 Suppl 9):13-8. PubMed ID: 12375796 [TBL] [Abstract][Full Text] [Related]
7. Role of topoisomerase I inhibitors in small-cell lung cancer. Fukuoka M Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234 [TBL] [Abstract][Full Text] [Related]
8. Irinotecan in combined-modality therapy for locally advanced non-small-cell lung cancer. Choy H; MacRae R Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):31-6. PubMed ID: 11221019 [TBL] [Abstract][Full Text] [Related]
9. Current role of irinotecan in the treatment of non-small-cell lung cancer. Kelly K Oncology (Williston Park); 2002 Sep; 16(9):1153-62, 1165; discussion 1165-6 passim. PubMed ID: 12380945 [TBL] [Abstract][Full Text] [Related]
10. Irinotecan in the treatment of small cell lung cancer. Masuda N; Fukuoka M Expert Rev Anticancer Ther; 2001 Aug; 1(2):187-95. PubMed ID: 12113024 [TBL] [Abstract][Full Text] [Related]
11. [Taxol in bronchial carcinoma]. Gatzemeier U Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171 [No Abstract] [Full Text] [Related]
12. [Role of irinotecan in the treatment of small cell carcinoma]. Crinò L Tumori; 2001; 87(6):A35-7. PubMed ID: 11995707 [No Abstract] [Full Text] [Related]
13. Irinotecan in small-cell lung cancer--Japanese trials. Fukuoka M; Masuda N; Kudoh S; Negoro S Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):57-62. PubMed ID: 10981292 [TBL] [Abstract][Full Text] [Related]
14. Irinotecan and radiation in combined-modality therapy for solid tumors. Choy H; MacRae R Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):22-8. PubMed ID: 11497228 [TBL] [Abstract][Full Text] [Related]
15. New state of the art in small-cell lung cancer. Tamura T Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):8-10. PubMed ID: 11221023 [TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical trials of topoisomerase inhibitors. Saijo N Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928 [TBL] [Abstract][Full Text] [Related]
17. Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer. Adjei AA; Argiris A; Murren JR Semin Oncol; 1999 Oct; 26(5 Suppl 16):32-40; discussion 41-2. PubMed ID: 10585007 [TBL] [Abstract][Full Text] [Related]
18. Camptothecin and its analogs. An overview of their potential in cancer therapeutics. Muggia FM; Dimery I; Arbuck SG Ann N Y Acad Sci; 1996 Dec; 803():213-23. PubMed ID: 8993515 [TBL] [Abstract][Full Text] [Related]
19. Clinical studies of CPT-11 in Japan. Taguchi T Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():277-83. PubMed ID: 7661595 [No Abstract] [Full Text] [Related]